COVID-19

Latest news

‘Pressure building’ on routine vaccine manufacturing, says WHO official

Many routine vaccine manufacturers are also involved in COVID-19 vaccine manufacturing and development.

Unitaid chief: We need to ‘double down’ on R&D for COVID-19 treatment

Effective treatments could help prevent more deaths amid the slow rollout of COVID-19 vaccines in countries. But apart from dexamethasone, other repurposed drugs have not shown significant benefits for severe to critical COVID-19 patients.

How 'vaccine passports' could exacerbate global inequities

Devex looks at how the clamor for so-called vaccine passports by higher-income countries would likely affect the global south.

Devex Newswire: How the world reached 3 million COVID-19 deaths

In today's Newswire: How did we get to 3 million, Biden's refugee double take, and the U.K. reassures its critics.

How did we reach 3 million COVID-19 deaths?

Analyses never expected the world would reach this milestone — but now they expected COVID-19 to claim far more lives before vaccines can slow the virus.

COVID-19 vaccinations could decrease routine immunization for children

UNICEF is concerned that with overwhelmed health workers and health funds diverted to COVID-19 vaccine rollouts, fewer children might receive routine immunizations.

COVAX Facility seeks an additional $2B for COVID-19 vaccines

Despite global supply shortages, Gavi CEO Seth Berkley says available financing is still important for ensuring that COVAX can secure doses in the future.

Devex CheckUp: Is ivermectin the new hydroxychloroquine?

In today's CheckUp: Doctors debate whether COVID-19 patients should receive ivermectin, Nestlé’s WHO Foundation donation, and politics influence vaccines in Venezuela.

In COVID-19 vaccine race, rollouts are sometimes an afterthought

Shipping COVID-19 vaccines globally is not enough, health experts say. Funding and planning for in-country rollouts have, in some places, been neglected.

Exclusive: WHO Foundation pushes back against criticism over Nestlé donation

Advocates expressed concerns that the contribution would become a vehicle for multinational companies, such as Nestlé, to influence the work of WHO, and not a good start for the work of its foundation.

A cautionary tale? After hydroxychloroquine, attention turns to ivermectin

Ivermectin’s story shares similarities with hydroxychloroquine. Both drugs are cheap, widely available, and have been used to treat other diseases prior to COVID-19. But if it will have the same fate is yet to be determined.

See more coverage

News

Jobs

Funding

Recruitment

Events

Community

Engage with us